Newsroom

A total of $700,000 awarded to researchers at Temple, Children’s Hospital of Philadelphia, University of Pennsylvania and University of Delaware to Accelerate Technology Commercialization

Temple University Hospital has joined a pivotal clinical trial testing an investigational medical device developed for patients with COPD.

Researchers at the Lewis Katz School of Medicine at Temple University (LKSOM), in collaboration with scientists at the University of Cambridge, show that choline, an essential nutrient that functions in metabolism, is an endogenous activator of sigma-1 receptors, marking an important advance in cell biology.